SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 167 filers reported holding SAGE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,662,000 | +11.0% | 130,472 | +0.1% | 0.01% | +14.3% |
| Q3 2016 | $6,002,000 | +80.9% | 130,334 | +18.4% | 0.01% | +75.0% |
| Q2 2016 | $3,317,000 | +67.5% | 110,084 | +78.3% | 0.00% | +33.3% |
| Q1 2016 | $1,980,000 | -36.7% | 61,752 | +15.2% | 0.00% | -25.0% |
| Q4 2015 | $3,126,000 | +37.6% | 53,624 | -0.1% | 0.00% | +33.3% |
| Q3 2015 | $2,271,000 | -46.0% | 53,671 | -6.9% | 0.00% | -40.0% |
| Q2 2015 | $4,207,000 | +338.2% | 57,631 | +201.6% | 0.01% | +400.0% |
| Q1 2015 | $960,000 | +40.6% | 19,110 | +2.4% | 0.00% | 0.0% |
| Q4 2014 | $683,000 | +24.2% | 18,663 | +6.9% | 0.00% | 0.0% |
| Q3 2014 | $550,000 | – | 17,460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |